Plans unveiled for UK’s new global hub for cancer research and treatment

A new ‘roadmap’ document outlines how The London Cancer Hub will become a world-leading life-science campus specialising in cancer research, treatment, education and enterprise.

It calculates that The London Cancer Hub, based in Sutton, south London, will potentially create more than 13,000 jobs and will deliver at least two extra cancer drugs every five years.

Laws of nature predict cancer evolution

Cancers evolve over time in patterns governed by the same natural laws that drive physical and chemical processes as diverse as the flow of rivers or the brightness of stars, a new study reports.

Blood test picks out prostate cancer drug resistance

Research paves the way for information from a blood test to inform prostate cancer treatment in future

Nearly half of testicular cancer risk comes from inherited genetic faults

Research suggests genetic inheritance is much more important in testicular cancer than in most other cancer types

'Mutation-tracking' blood test

Could predict breast cancer relapse months in advance, says The Institute of Cancer Research

Chemists recruit anthrax to deliver cancer drugs

With some tinkering, a deadly protein becomes an efficient carrier for antibody drugs

Physicists reveal random nature of metastasis

The spreading of a cancerous tumour from one part of the body to another may occur through pure chance instead of key genetic mutations, a new study has shown

Mammalian cell division synchronises with body’s daily rhythm

Discovery could optimise timing of chemotherapy and explain some cancers, say researchers

Gene expression profiling boosts tailor-made treatment

Large amounts of information generated by gene expression profiling will increase implementation of data management tools

Optimise drug screening processes

Crown Bioscience to showcase progression in human surrogate trials at the 50th ASCO Annual Meeting

Sharks inspire custom-tailored antibodies in humans

Researchers chose the immunoglobulin new antigen receptor shark antibody for their investigations

Laser to give key insight into cell behaviour in nature

Laser instrument capable of hitting a sample a hundred thousand times a second is expected to provide scientists with vital information about the UV light-induced DNA damage that drives skin cancer

Queen’s leads €6million European study to combat bowel cancer

Queen’s University has announced it is to lead a €6 million European study to find new treatments for bowel cancer.

Nanoparticles can overcome drug resistance in breast cancer cells

Nanoparticles filled with chemotherapeutic drugs can kill drug-resistant breast cancer cells, according to a study published in the scientific journal Biomaterials.

Chemotherapy before radiotherapy for testicular cancer could reduce risk of relapse and long-term side-effects

Giving men with testicular cancer a single dose of chemotherapy alongside radiotherapy could improve the effectiveness of treatment and reduce the risk of long-term side-effects, a new study reports.
As many as 96% of men with testicular cancer now survive at least ten years from diagnosis, but more advanced forms need to be treated with combination chemotherapy – which can have serious long-term complications.

Understanding the effects of genes on human traits

Recent technological developments in genomics have revealed a large number of genetic influences on common complex diseases, such as diabetes, asthma, cancer or schizophrenia.

Men with incurable prostate cancer living for twice as long as decade ago

Patients with advanced prostate cancer treated with the latest therapies are living on average for more than twice as long as a decade ago, a striking new analysis reveals.

"Intelligent knife" tells surgeon which tissue is cancerous

Scientists have developed an "intelligent knife" that can tell surgeons immediately whether the tissue they are cutting is cancerous or not.

Roche launches new ProGRP test for more precise diagnosis in lung cancer

New test expands cancer diagnostics portfolio and strengthens Roche Diagnostics’ comprehensive tumour marker menu.

‘Homing’ radioactive injection shows benefit in phase III prostate cancer trial

An ingenious new treatment for advanced prostate cancer, which homes in on tumours to deliver a high-energy burst of radiation to cancer cells, has shown significant benefits to patients in a large-scale clinical trial.






To receive the Scientist Live weekly email NewsBrief please enter your details below

Twitter Icon © Setform Limited